AZTherapies, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2011-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.aztherapies.com
Randomized I/II Phase Study of ALZT-OP1 Combination Therapy in Alzheimer's Disease and Normal Healthy Volunteers
Phase 1
Completed
- Conditions
- Alzheimer DiseaseHealthy Volunteers
- Interventions
- Drug: ALZT-OP1 (cromolyn and ibuprofen) ALZT-OP1a (cromolyn) and ALZT-OP1b (ibuprofen)
- First Posted Date
- 2020-09-30
- Last Posted Date
- 2022-03-03
- Lead Sponsor
- AZTherapies, Inc.
- Target Recruit Count
- 56
- Registration Number
- NCT04570644
- Locations
- 🇺🇸
Panax Clinical Research, Miami Lakes, Florida, United States
A Safety and Biomarker Study of ALZT-OP1a in Subjects With Mild-Moderate ALS Disease
Phase 2
Terminated
- Conditions
- Amyotrophic Lateral Sclerosis
- Interventions
- Drug: ALZT-OP1a (cromolyn)
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2021-11-08
- Lead Sponsor
- AZTherapies, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT04428775
- Locations
- 🇺🇸
Columbia University Medical Center, New York, New York, United States
🇺🇸Mayo Clinic, Jacksonville, Florida, United States
🇺🇸UCSD Altman Clinical and Translational Research Institute, La Jolla, California, United States
Safety and Efficacy of ALZT-OP1a as Adjuvant Treatment in Subjects With Post-Ischemic Stroke Cognitive Impairment (PSCI)
Phase 2
Withdrawn
- Conditions
- Ischemic StrokePost-stroke Cognitive Impairment
- Interventions
- Other: Placebo
- First Posted Date
- 2017-06-28
- Last Posted Date
- 2022-03-03
- Lead Sponsor
- AZTherapies, Inc.
- Registration Number
- NCT03202147
Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease
Phase 3
Completed
- Conditions
- Alzheimer's Disease
- Interventions
- First Posted Date
- 2015-09-11
- Last Posted Date
- 2021-11-10
- Lead Sponsor
- AZTherapies, Inc.
- Target Recruit Count
- 620
- Registration Number
- NCT02547818
- Locations
- 🇺🇸
Syrentys Clinical Research, Santa Ana, California, United States
🇺🇸CITrials, Riverside, California, United States
🇺🇸Parkinson's Disease & Movement Disorders Center of Boca Raton, Boca Raton, Florida, United States
Phase 1 Study of ALZT-OP1 Combination Therapy in Normal Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2015-06-26
- Last Posted Date
- 2015-07-21
- Lead Sponsor
- AZTherapies, Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT02482324
- Locations
- 🇺🇸
Panax Clinical Research, Miami Lakes, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath